Page 42 - Read Online

Page 38 Benusa et al. Neuroimmunol Neuroinflammation 2020;7:23-39 I http://dx.doi.org/10.20517/2347-8659.2019.28

Neurobiol. 2013;39:3-18.
124. Engel S, Schluesener H, Mittelbronn M, Seid K, Adjodah D, et al. Dynamics of microglial activation after human traumatic brain
injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol 2000;100:313-22.
125. Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, et al. Inflammation and white matter degeneration persist for years
after a single traumatic brain injury. Brain 2013;136:28-42.
126. Engel S, Isenmann S, Ständer M, Rieger J, Bähr M, et al. Inhibition of experimental rat glioma growth by decorin gene transfer is
associated with decreased microglial infiltration. J Neuroimmunol 1999;99:13-8.
127. Marklund N. Rodent models of traumatic brain injury: methods and challenges. Methods Mol Biol 2016;1462:29-46.
128. Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci 2013;14:128-42.
129. Donat CK, Scott G, Gentleman SM, Sastre M. Microglial activation in traumatic brain injury. Front Aging Neurosci 2017;9:208.
130. Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res 2015;1619:1-11.
131. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, et al. Identification of two distinct macrophage subsets with divergent
effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009;29:13435-44.
132. Loane DJ, Kumar A, Stoica BA, Cabatbat R, Faden AI. Progressive neurodegeneration after experimental brain trauma: association
with chronic microglial activation. J Neuropathol Exp Neurol 2014;73:14-29.
133. Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J. Neuroimmunology of traumatic brain injury: time for a paradigm shift.
Neuron 2017;95:1246-65.
134. Tapp ZM, Godbout JP, Kokiko-Cochran ON. A tilted axis: maladaptive inflammation and HPA axis dysfunction contribute to
consequences of TBI. Front Neurol 2019;10:345.
135. Zanier ER, Marchesi F, Ortolano F, Perego C, Arabian M, et al. Fractalkine receptor deficiency is associated with early protection but
late worsening of outcome following brain trauma in mice. J Neurotrauma 2016;33:1060-72.
136. Weber MD, McKim DB, Niraula A, Witcher KG, Yin W, et al. The influence of microglial elimination and repopulation on stress
sensitization induced by repeated social defeat. Biol Psychiatry 2019;85:667-78.
137. d’Avila JC, Lam TI, Bingham D, Shi J, Won SJ, et al. Microglial activation induced by brain trauma is suppressed by post-injury
treatment with a PARP inhibitor. J Neuroinflammation 2012;9:31.
138. Siopi E, Llufriu-Dabén G, Fanucchi F, Plotkine M, Marchand-Leroux C, et al. Evaluation of late cognitive impairment and anxiety
states following traumatic brain injury in mice: the effect of minocycline. Neurosci Lett 2012;511:110-5.
139. Eyo UB, Gu N, De S, Dong H, Richardson JR, et al. Modulation of microglial process convergence toward neuronal dendrites by
extracellular calcium. J Neurosci 2015;35:2417-22.
140. Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169:337-52.
141. Homsi S, Federico F, Croci N, Palmier B, Plotkine M, et al. Minocycline effects on cerebral edema: relations with inflammatory and
oxidative stress markers following traumatic brain injury in mice. Brain Res 2009;1291:122-32.
142. Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue
damage, and neurological dysfunction. Neurosurgery 2001;48:1393-9.
143. Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, et al. Minocycline treatment reduces delayed oligodendrocyte death,
attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 2004;24:2182-90.
144. Meythaler J, Fath J, Fuerst D, Zokary H, Freese K, et al. Safety and feasibility of minocycline in treatment of acute traumatic brain
injury. Brain Inj 2019;33:679-89.
145. Bye N, Habgood MD, Callaway JK, Malakooti N, Potter A, et al. Transient neuroprotection by minocycline following traumatic
brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol
2007;204:220-33.
146. Hanlon LA, Raghupathi R, Huh JW. Differential effects of minocycline on microglial activation and neurodegeneration following
closed head injury in the neonate rat. Exp Neurol 2017;290:1-14.
147. Lopez-Rodriguez AB, Siopi E, Finn DP, Marchand-Leroux C, Garcia-Segura LM, et al. CB1 and CB2 cannabinoid receptor
antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice. Cereb Cortex 2015;25:35-45.
148. Simon DW, Aneja RK, Alexander H, Bell MJ, Bayır H, et al. Minocycline attenuates high mobility group box 1 translocation,
microglial activation, and thalamic neurodegeneration after traumatic brain injury in post-natal day 17 Rats. J Neurotrauma
2018;35:130-8.
149. Bachstetter AD, Zhou Z, Rowe RK, Xing B, Goulding DS, et al. MW151 inhibited IL-1β levels after traumatic brain injury with no
effect on microglia physiological responses. PLoS One 2016;11:e0149451.
150. Witcher KG, Bray CE, Dziabis JE, McKim DB, Benner BN, et al. Traumatic brain injury-induced neuronal damage in the
somatosensory cortex causes formation of rod-shaped microglia that promote astrogliosis and persistent neuroinflammation. Glia
2018;66:2719-36.
151. Henry RJ, Ritzel RM, Barrett JP, Doran SJ, Jiao Y, et al. Microglial depletion with CSF1R inhibitor during chronic phase of
experimental traumatic brain injury reduces neurodegeneration and neurological deficits. J Neurosci 2020:2402-19.
152. Büki A, Povlishock JT. All roads lead to disconnection?--Traumatic axonal injury revisited. Acta Neurochir (Wien) 2006;148:181-93.
153. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. Beta-amyloid precursor protein (beta APP) as a marker for axonal
injury after head injury. Neurosci Lett 1993;160:139-44.
154. Johnson VE, Stewart W, Weber MT, Cullen DK, Siman R, et al. SNTF immunostaining reveals previously undetected axonal
pathology in traumatic brain injury. Acta Neuropathol 2016;131:115-35.
155. Povlishock JT, Erb DE, Astruc J. Axonal response to traumatic brain injury: reactive axonal change, deafferentation, and
neuroplasticity. J Neurotrauma 1992;9:S189-200.
156. Sherriff FE, Bridges LR, Gentleman SM, Sivaloganathan S, Wilson S. Markers of axonal injury in post mortem human brain. Acta